FDA Inspection 1125294 — UCSF Radiopharmaceutical Facility

UCSF Radiopharmaceutical Facility — FEI 3005947301

The FDA completed an inspection of UCSF Radiopharmaceutical Facility on Jul 24, 2020 in San Francisco, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 24, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Francisco, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.